Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-25-040421
Filing Date
2025-03-17
Accepted
2025-03-17 16:54:10
Documents
25

Document Format Files

Seq Description Document Type Size
1 S-3 mgx-20250317.htm S-3 674562
2 EX-1.2 mgx-ex1_2.htm EX-1.2 420448
3 EX-4.5 mgx-ex4_5.htm EX-4.5 650353
4 EX-4.6 mgx-ex4_6.htm EX-4.6 662751
5 EX-5.1 mgx-ex5_1.htm EX-5.1 34231
6 EX-5.2 mgx-ex5_2.htm EX-5.2 19729
7 EX-23.1 mgx-ex23_1.htm EX-23.1 4142
8 EX-FILING FEES mgx_exfilingfees.htm   iXBRL EX-FILING FEES 96343
9 GRAPHIC img192705560_0.jpg GRAPHIC 14523
10 GRAPHIC img193629081_0.jpg GRAPHIC 14523
11 GRAPHIC img244679353_0.jpg GRAPHIC 246742
12 GRAPHIC img244679353_1.jpg GRAPHIC 47124
13 GRAPHIC img244679353_2.jpg GRAPHIC 49698
14 GRAPHIC img244679353_3.jpg GRAPHIC 49693
  Complete submission text file 0000950170-25-040421.txt   3303744

Data Files

Seq Description Document Type Size
27 EXTRACTED XBRL INSTANCE DOCUMENT mgx_exfilingfees_htm.xml XML 16519
Mailing Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608
Business Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 (510) 871-4880
Metagenomi, Inc. (Filer) CIK: 0001785279 (see all company filings)

EIN.: 813909017 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-285867 | Film No.: 25745339
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)